- 2017
-
Press releases - 20.07.2017
9th IAS Conference on HIV
From July 23 to 26, 2017, the Ninth IAS Conference on HIV Science, of which Inserm is a partner, will be held at the Palais des Congrès in Paris. For this edition, the International AIDS Society (IAS) has teamed up with ANRS, the autonomous agency of Inserm, to coordinate and fund research on HIV/AIDS and hepatitis.
-
What's on? - 20.07.2017
9th IAS Conference on HIV
From July 23 to 26, 2017, the Ninth IAS Conference on HIV Science, of which Inserm is a partner, will be held at the Palais des Congrès in Paris. For this edition, the International AIDS Society (IAS) has teamed up with ANRS, the autonomous agency of Inserm, to coordinate and fund research on HIV/AIDS and […]
-
Press releases - 13.07.2017
Hereditary hearing loss: the ear and auditory brain are both affected
Scientists from the Institut Pasteur, Inserm, the Collège de France and Pierre & Marie Curie University have recently demonstrated that mutations in three genes responsible for Usher syndrome – a hereditary condition that affects both hearing and sight – influence not only the workings of the ear, specifically the function of sensory cells in the cochlea, but also the development of the auditory cortex. Their discovery could explain why some patients, even after being fitted with a cochlear implant (an electro-acoustic device that bypasses the defective cochlea), still have difficulties understanding speech. The findings are reported this week in a paper in the Proceedings of the National Academy of Sciences of the USA.
-
Press releases - 13.07.2017
Vision restoration by optogenetic therapy within easy reach?
The Vision Institute (Inserm, Université Pierre et Marie Curie (UPMC), National Center for Scientific Research (CNRS)) via the Fondation Voir & Entendre has signed a contract with the United States Defense Advanced Research Projects Agency (DARPA), which could ultimately represent $ 25 million. With the help of an international consortium, researchers from Inserm, CNRS and UPMC, working within the Vision Institute, want to develop a system capable of restoring vision by optogenetic stimulation of the visual cortex. This project is called CorticalSight.
-
Press releases - 12.07.2017
Phage therapy : synergy between bacteriophages and the immune system is essential
Phage therapy involves the use of bacteriophages, or phages, for treating bacterial infections. Phages are viruses that specifically attack bacteria and are harmless to humans. A significant decline in the use of this therapeutic strategy introduced 100 years ago was seen in the West following the development of antibiotics. However, there is now new interest in phage therapy, especially in Europe, given the alarming increase in the number of antibiotic-resistant bacterial infections.
-
Press releases - 11.07.2017
What life expectancy in good health?
Life expectancy has been on the increase for several decades in Western countries. But what about life expectancy in good health?
It is clear that the increase in life expectancy is a new source of inequality between men and women in terms of disability. -
What's on? - 11.07.2017
What life expectancy in good health?
Life expectancy has been on the increase for several decades in Western countries. But what about life expectancy in good health? It is clear that the increase in life expectancy is a new source of inequality between men and women in terms of disability. The work of Jean-Marie Robine (Inserm unit 1198 “Molecular mechanisms in neurodegenerative […]
-
Press releases - 10.07.2017
An antidiabetic drug moves a step forward
In humans, apelin is able to regulate blood sugar levels and increase the sensitivity of cells to insulin. These two observations have paved the way for a clinical trial led by Inserm researchers from Toulouse, and represent a promising step forward for the development of a new treatment for diabetes, in particular type 2 diabetes.
-
Press releases - 06.07.2017
Physical activity does not protect against the onset of dementia
Physical activity in adulthood is not associated with a reduced risk of developing dementia. However, a decline in this activity is observed during the decade preceding its diagnosis. If this decline in activity cannot be considered as an early sign of dementia, it could be one sign – among others – to be taken into account by the attending physician. This is demonstrated by a study conducted by an Inserm research team of the Center for Research in Epidemiology and Public Health (Unit 1018 Inserm / Université Paris-Saclay).
-
Press releases - 05.07.2017
Gut bacteria can help to predict how the body will respond to fatty foods
Scientists have found that certain compounds, produced by microbes in the guts of mice, could be used to show which animals are at greater risk of becoming obese, or developing health conditions such as diabetes or cardiovascular disease.